SCHEMBL4384280

SCHEMBL4384280

COC(=O)OC(C)C(CCCCCCCCC(=O)O)(C(=O)O)C(C)OC(=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
ADRA1A P35348 1/20 0.39
TSHR P16473 6/20 0.38
LMNA P02545 1/20 0.38
NFKB1 P19838 1/20 0.38
PMP22 Q01453 1/20 0.38
GPR84 Q9NQS5 7/20 0.36
PPARG P37231 7/20 0.36
PPARD Q03181 7/20 0.36
PPARA Q07869 7/20 0.36
HDAC11 Q96DB2 5/20 0.36
PTPN1 P18031 3/20 0.36
TLR2 O60603 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
FABP4 P15090 2/20 0.36
SLC22A6 Q4U2R8 1/20 0.36
SLC22A8 Q8TCC7 1/20 0.36
MEN1 O00255 1/20 0.36
ESR1 P03372 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4388232 1.00 ALDH1A1 (0.41) ALDH1A1ADRA1ATSHRLMNANFKB1
SCHEMBL4395467 1.00 ALDH1A1 (0.41) ALDH1A1ADRA1ATSHRLMNANFKB1
SCHEMBL4386105 1.00 ALDH1A1 (0.41) ALDH1A1ADRA1ATSHRLMNANFKB1
SCHEMBL4388236 1.00 ALDH1A1 (0.41) ALDH1A1ADRA1ATSHRLMNANFKB1
SCHEMBL4394670 0.98 TSHR (0.39) ALDH1A1ADRA1ATSHRLMNANFKB1
SCHEMBL4384333 0.94 TSHR (0.40) ALDH1A1ADRA1ATSHRLMNANFKB1
SCHEMBL4388745 0.87 GPR84 (0.37) ALDH1A1TSHRLMNANFKB1PMP22
SCHEMBL4396165 0.87 GPR84 (0.37) ALDH1A1TSHRLMNANFKB1PMP22
SCHEMBL4387905 0.87 GPR84 (0.37) ALDH1A1TSHRLMNANFKB1PMP22
SCHEMBL4388293 0.87 GPR84 (0.37) ALDH1A1TSHRLMNANFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629383-B2 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2009-12-08 US disclosed
US-20050203181-A1 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203181-A1 Double esters ACACA, CES1, ACACB ALDH1A1 296/4885ADRA1A 3067/4885TSHR 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.